Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice.
Zhi ZhangJae Whan ParkIn Sook AhnGraciel DiamanteNilla SivakumarDouglas ArnesonXia YangJ Edward Van VeenStephanie M CorreaPublished in: eLife (2021)
Adjuvant tamoxifen therapy improves survival in breast cancer patients. Unfortunately, long-term treatment comes with side effects that impact health and quality of life, including hot flashes, changes in bone density, and fatigue. Partly due to a lack of proven animal models, the tissues and cells that mediate these negative side effects are unclear. Here, we show that mice undergoing tamoxifen treatment experience changes in temperature, bone, and movement. Single-cell RNA sequencing reveals that tamoxifen treatment induces widespread gene expression changes in the hypothalamus and preoptic area (hypothalamus-POA). These expression changes are dependent on estrogen receptor alpha (ERα), as conditional knockout of ERα in the hypothalamus-POA ablates or reverses tamoxifen-induced gene expression. Accordingly, ERα-deficient mice do not exhibit tamoxifen-induced changes in temperature, bone, or movement. These findings provide mechanistic insight into the effects of tamoxifen on the hypothalamus-POA and indicate that ERα mediates several physiological effects of tamoxifen treatment in mice.
Keyphrases
- estrogen receptor
- gene expression
- breast cancer cells
- single cell
- positive breast cancer
- dna methylation
- bone mineral density
- poor prognosis
- mesenchymal stem cells
- mental health
- type diabetes
- physical activity
- early stage
- metabolic syndrome
- cell proliferation
- skeletal muscle
- risk assessment
- long non coding rna
- sleep quality
- endoplasmic reticulum
- blood brain barrier
- subarachnoid hemorrhage
- free survival